Thermo Fisher Scientific Competitors & Alternatives
Thermo Fisher Scientific competitors and alternatives include Agilent Technologies, Danaher Corporation, etc.…
Jump
-
Stock Price
-
Market Cap
-
Employees
-
Income Statement
-
Revenue
-
Revenue by Product / Services
-
Revenue by Geography
-
Research and Development
-
Operating Income
-
Tax Rate (%)
-
Net Income
-
Assets & Liabilities | Cash Flow
-
Total Assets
-
Total Liabilities
-
Capital Expenditures (Capex)
-
Profitability
-
Operating Income Margin (%)
-
Net Income Margin (%)
-
EBITDA
-
Free Cash Flow (FCF)
-
Ratios
-
Return on Equity (ROE)
-
Return on Assets (ROA)
-
Debt to Equity
-
Valuation
-
Enterprise value
-
Enterprise value to Revenue
-
Enterprise value to EBITDA
Ticker
TMO
A
DHR
Headquarter
Waltham
,MA
US
Santa Clara
,CA
US
Washington
,DC
US
CEO
Industry
Medical - Diagnostics & Research
Medical - Diagnostics & Research
Medical - Diagnostics & Research
Stock Price
Stock Price
Market Cap
Market Cap
$230.08 B
$41.48 B
$168.78 B
Employees
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Employees
- 130.00 K
- 122.00 K
- 125.00 K
- 18.10 K
- 17.90 K
- 18.10 K
- 81.00 K
- 63.00 K
- 63.00 K
Y/Y
0%
6.15%
2.46%
0%
1.1%
1.12%
1.25%
22.22%
0%
Income Statement
Revenue
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Revenue
- $44.92 B
- $42.86 B
- $42.88 B
- $6.83 B
- $6.51 B
- $6.95 B
- $26.64 B
- $23.89 B
- $23.88 B
Y/Y
14.55%
4.58%
0.05%
0.22%
4.73%
6.73%
9.54%
10.33%
0.06%
Revenue by Products / Services
Years
- 2024
- 2025
- 2024
Revenue by Geography
Years
- 2024
- 2025
- 2024
Research and Development
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Research and Development
- $1.47 B
- $1.34 B
- $1.39 B
- $481.00 M
- $479.00 M
- $455.00 M
- $1.53 B
- $1.50 B
- $1.58 B
Y/Y
4.62%
9.11%
3.96%
3%
0.42%
5.01%
12.28%
1.64%
5.39%
Operating Income
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Operating Income
- $8.53 B
- $7.45 B
- $7.66 B
- $1.35 B
- $1.49 B
- $1.48 B
- $7.54 B
- $5.28 B
- $5.18 B
Y/Y
17.38%
12.66%
2.9%
16.56%
10.22%
0.6%
6.39%
29.95%
1.8%
Tax Rate (%)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Tax Rate (%)
- 9.17%
- 4.55%
- 9.39%
- 7.39%
- 15.25%
- 9.20%
- 11.45%
- 16.32%
- 16.08%
Y/Y
26.9%
50.38%
106.34%
55.52%
106.3%
39.69%
30.48%
42.54%
1.46%
Net Income
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Net Income
- $6.95 B
- $6.00 B
- $6.34 B
- $1.24 B
- $1.29 B
- $1.30 B
- $7.21 B
- $4.76 B
- $3.90 B
Y/Y
10.03%
13.74%
5.67%
1.12%
3.95%
1.09%
12.06%
33.92%
18.16%
Revenue Per Employee
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Revenue Per Employee
- $329.67 K
- $351.47 K
- -
- $377.51 K
- $363.69 K
- $383.87 K
- $294.94 K
- $378.97 K
- -
Y/Y
4.58%
6.61%
100%
0.22%
3.66%
5.55%
11.44%
28.49%
100%
Net Income Per Employee
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Net Income Per Employee
- $46.12 K
- $51.93 K
- -
- $68.51 K
- $72.01 K
- $71.99 K
- $58.81 K
- $61.89 K
- -
Y/Y
13.74%
12.6%
100%
1.12%
5.11%
0.03%
34.73%
5.23%
100%
Assets & Liabilities | Cash Flow
Total Assets
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Total Assets
- $97.15 B
- $98.73 B
- $97.32 B
- $10.76 B
- $11.85 B
- $12.73 B
- $84.35 B
- $84.49 B
- $77.54 B
Y/Y
2.14%
1.62%
1.42%
2.19%
10.06%
7.44%
1.4%
0.16%
8.22%
Total Liabilities
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Total Liabilities
- $53.01 B
- $51.88 B
- $47.65 B
- $4.92 B
- $5.95 B
- $5.99 B
- $34.26 B
- $31.00 B
- $27.99 B
Y/Y
2.11%
2.12%
8.16%
5.91%
20.94%
0.64%
9.86%
9.52%
9.7%
Capital Expenditures (Capex)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Capital Expenditures (Capex)
- -$2.24 B
- -$1.48 B
- -$1.40 B
- -$298.00 M
- -$378.00 M
- -$407.00 M
- -$1.15 B
- -$1.38 B
- -$1.39 B
Y/Y
11.1%
34.06%
5.34%
2.41%
26.85%
7.67%
10.97%
20.05%
0.65%
Profitability
Operating Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Operating Income Margin (%)
- 18.98%
- 17.37%
- 17.87%
- 19.76%
- 22.86%
- 21.29%
- 28.29%
- 22.10%
- 21.71%
Y/Y
27.87%
8.46%
2.85%
16.38%
15.69%
6.87%
3.49%
21.88%
1.74%
Net Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Net Income Margin (%)
- 15.47%
- 13.99%
- 14.77%
- 18.15%
- 19.80%
- 18.75%
- 27.06%
- 19.94%
- 16.33%
Y/Y
21.46%
9.6%
5.62%
0.9%
9.11%
5.29%
23.88%
26.3%
18.11%
EBITDA
| 2021 | 11969000000.00 |
|---|---|
| 2022 | 11942000000.00 |
| 2023 | 11195000000.00 |
| 2024 | 11800000000.00 |
| 2022 | 1905000000.00 |
|---|---|
| 2023 | 1703000000.00 |
| 2024 | 1874000000.00 |
| 2025 | 1835000000.00 |
| 2021 | 10007000000.00 |
|---|---|
| 2022 | 9485000000.00 |
| 2023 | 7499000000.00 |
| 2024 | 7276000000.00 |
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
EBITDA
- $11.94 B
- $11.20 B
- $11.80 B
- $1.70 B
- $1.87 B
- $1.84 B
- $9.49 B
- $7.50 B
- $7.28 B
Y/Y
0.23%
6.26%
5.4%
10.6%
10.04%
2.08%
5.22%
20.94%
2.97%
Free Cash Flow (FCF)
| 2021 | 7020000000.00 |
|---|---|
| 2022 | 6911000000.00 |
| 2023 | 6927000000.00 |
| 2024 | 7267000000.00 |
| 2022 | 1021000000.00 |
|---|---|
| 2023 | 1474000000.00 |
| 2024 | 1373000000.00 |
| 2025 | 1152000000.00 |
| 2021 | 7064000000.00 |
|---|---|
| 2022 | 7367000000.00 |
| 2023 | 5781000000.00 |
| 2024 | 5296000000.00 |
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Free Cash Flow (FCF)
- $6.91 B
- $6.93 B
- $7.27 B
- $1.47 B
- $1.37 B
- $1.15 B
- $7.37 B
- $5.78 B
- $5.30 B
Y/Y
1.55%
0.23%
4.91%
44.37%
6.85%
16.1%
4.29%
21.53%
8.39%
Ratios
Return on Equity (ROE)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Return on Equity (ROE)
- 15.80%
- 12.83%
- 12.78%
- 21.21%
- 21.85%
- 6.44%
- 14.39%
- 8.91%
- 7.87%
Y/Y
16.55%
18.83%
0.4%
10.25%
3.02%
70.54%
1.07%
38.12%
11.64%
Return on Assets (ROA)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Return on Assets (ROA)
- 7.15%
- 6.07%
- 6.51%
- 11.52%
- 10.88%
- 3.41%
- 8.55%
- 5.64%
- 5.03%
Y/Y
11.91%
15.11%
7.2%
3.24%
5.55%
68.66%
10.51%
34.02%
10.83%
Debt to Equity
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Debt to Equity
- 82.03%
- 77.94%
- 66.10%
- 46.79%
- 60.60%
- 49.76%
- 41.16%
- 36.53%
- 34.61%
Y/Y
7.92%
4.98%
15.19%
10.35%
29.5%
17.89%
20.11%
11.27%
5.25%
Valuation
Enterprise Value
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Enterprise value
- $243.42 B
- $233.23 B
- $227.49 B
- $31.54 B
- $40.03 B
- $42.98 B
- $185.22 B
- $184.05 B
- $182.87 B
Y/Y
17.42%
4.19%
2.46%
26.8%
26.95%
7.37%
19.15%
0.63%
0.64%
Enterprise value to Revenue
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Enterprise value to Revenue
- 5.42
- 5.44
- 5.31
- 4.62
- 6.15
- 23.10
- 6.95
- 7.70
- 7.66
Y/Y
27.9%
0.41%
2.51%
26.64%
33.25%
275.59%
10.62%
10.82%
0.58%
Enterprise value to EBITDA
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
- 2022
- 2023
- 2024
Enterprise value to EBITDA
- 20.38
- 20.83
- 19.28
- 18.52
- 21.36
- 58.80
- 19.53
- 24.54
- 25.13
Y/Y
17.23%
2.21%
7.46%
18.12%
15.37%
175.25%
14.7%
25.69%
2.4%





